These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29673525)

  • 21. Optogenetics and pharmacogenetics: principles and applications.
    Jiang J; Cui H; Rahmouni K
    Am J Physiol Regul Integr Comp Physiol; 2017 Dec; 313(6):R633-R645. PubMed ID: 28794102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acoustically targeted chemogenetics for the non-invasive control of neural circuits.
    Szablowski JO; Lee-Gosselin A; Lue B; Malounda D; Shapiro MG
    Nat Biomed Eng; 2018 Jul; 2(7):475-484. PubMed ID: 30948828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anesthetic Drug Discovery and Development: A Case Study of Novel Etomidate Analogs.
    McGrath M; Raines DE
    Methods Enzymol; 2018; 603():153-169. PubMed ID: 29673523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Use of DREADDs to Deconstruct Behavior.
    Whissell PD; Tohyama S; Martin LJ
    Front Genet; 2016; 7():70. PubMed ID: 27242888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Common Neuroendocrine Substrate for Diverse General Anesthetics and Sleep.
    Jiang-Xie LF; Yin L; Zhao S; Prevosto V; Han BX; Dzirasa K; Wang F
    Neuron; 2019 Jun; 102(5):1053-1065.e4. PubMed ID: 31006556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.
    Saloman JL; Scheff NN; Snyder LM; Ross SE; Davis BM; Gold MS
    J Neurosci; 2016 Oct; 36(42):10769-10781. PubMed ID: 27798132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview on Research and Clinical Applications of Optogenetics.
    Towne C; Thompson KR
    Curr Protoc Pharmacol; 2016 Dec; 75():11.19.1-11.19.21. PubMed ID: 27960028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vivo Intracerebral Stereotaxic Injections for Optogenetic Stimulation of Long-Range Inputs in Mouse Brain Slices.
    Richevaux L; Schenberg L; Beraneck M; Fricker D
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31589202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders.
    Cho KK; Sohal VS
    Hum Mol Genet; 2014 Sep; 23(R1):R64-8. PubMed ID: 24824218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Chemogenetics and Optogenetics to Dissect Brain-Immune Interactions.
    Korin B; Rolls A
    Methods Mol Biol; 2018; 1781():195-208. PubMed ID: 29705849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral Vector Delivery of DREADDs for CNS Therapy.
    Pickering CA; Mazarakis ND
    Curr Gene Ther; 2021; 21(3):191-206. PubMed ID: 33573551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemogenetic Targeting of Dorsomedial Direct-pathway Striatal Projection Neurons Selectively Elicits Rotational Behavior in Mice.
    Bay Kønig A; Ciriachi C; Gether U; Rickhag M
    Neuroscience; 2019 Mar; 401():106-116. PubMed ID: 30668973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity.
    Zhan J; Komal R; Keenan WT; Hattar S; Fernandez DC
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31498301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pharmacogenetic activation of medial prefrontal cortex excitatory neurons regulates anxiety-like behaviour.
    Pati S; Sood A; Mukhopadhyay S; Vaidya VA
    J Biosci; 2018 Mar; 43(1):85-95. PubMed ID: 29485117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.
    Parusel S; Yi MH; Hunt CL; Wu LJ
    Neurosci Bull; 2023 Mar; 39(3):368-378. PubMed ID: 35976535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.
    Ozawa A; Arakawa H
    Behav Brain Res; 2021 May; 406():113234. PubMed ID: 33741409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools.
    Boehm MA; Bonaventura J; Gomez JL; Solís O; Stein EA; Bradberry CW; Michaelides M
    Pharmacol Biochem Behav; 2021 May; 204():173147. PubMed ID: 33549570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemogenetic stimulation of the hypoglossal neurons improves upper airway patency.
    Fleury Curado T; Fishbein K; Pho H; Brennick M; Dergacheva O; Sennes LU; Pham LV; Ladenheim EE; Spencer R; Mendelowitz D; Schwartz AR; Polotsky VY
    Sci Rep; 2017 Mar; 7():44392. PubMed ID: 28281681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.
    Weston M; Kaserer T; Wu A; Mouravlev A; Carpenter JC; Snowball A; Knauss S; von Schimmelmann M; During MJ; Lignani G; Schorge S; Young D; Kullmann DM; Lieb A
    Sci Adv; 2019 Apr; 5(4):eaaw1567. PubMed ID: 31001591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opto-chemogenetics with luminopsins: A novel avenue for targeted control of neuronal activity.
    Berglund K; Gross RE
    J Neurosci Res; 2020 Mar; 98(3):407-409. PubMed ID: 31157461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.